Experts in medical science are expressing concern over recent funding cuts to university labs, arguing they will slow down or halt fundamental research that leads to significant medical innovations. Notable figures, such as Harvard's Robert Huckman, suggest that if these funding reductions persist, pharmaceutical prices could rise and there might be a notable decrease in new therapies introduced in the next decade. Isaac Kohlberg warns of a potential collapse in the U.S. innovation ecosystem if academic research resources are not prioritized, highlighting the critical role of university research in developing new treatments.
If one thinks pharmaceutical prices are high today, it is safe to assume they will become even more so in the face of these funding reductions.
If these grants are not restored, it would not be surprising to me if 10 years from now, we see a markedly lower number of therapies coming to market.
If you attack the foundation of the building, the building will collapse. Academic innovations are the foundation of many products and services that reach consumers.
Collection
[
|
...
]